The event is an earnings conference call to discuss the company's first quarter financial results ended 30 June 2026.
The call is scheduled for Friday, 31 July 2026 at 06:30 PM IST and will last for one hour.
The purpose is for senior management to discuss the company's performance and answer questions from participants.
The earnings results will be announced on 31 July 2026, before the conference call.
Management participants are not specifically named, but "senior management" will be conducting the call.
The results will be available on the company website www.sunpharma.com. An audio webcast will be available, with details to be announced later on the website. A transcript of the conference call will also be available on the website.
The document includes standard forward-looking statement disclaimer language but does not specifically mention whether unpublished price sensitive information (UPSI) will be shared.
Additional Notes Section
The document includes contact information for Dr. Abhishek Sharma (Tel: +91 22 4324 4324 Xtn 2929, Mobile: +91 98196 86016, Email: abhi.sharma@sunpharma.com) and Gaurav Chugh (Tel: +91 22 4324 4324 Xtn 5373, Mobile: +91 98104 71414, Email: gaurav.chugh@sunpharma.com).
No financial data or actual results are disclosed in this announcement.
Participants are required to pre-register using the DiamondPassRegistration link to avoid wait time.
Telephone numbers for the conference call are provided: Universal Number: +91 22 6629 0049 and +91 22 7194 5729.
